PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway
Open Access
Abstract
Through facilitating DNA homologous recombination repair, PPIP5K2 has been proven to be essential for improving colorectal cancer survival in our previous research. However, its function in the tumorigenesis of NSCLC, the most common cancer and the primary cause of cancer-related death globally, is still unknown. Here, we initially discovered that PPIP5K2 had significant effects on proliferation of NSCLC cells through loss- and gain-of-function assays in vitro and in vivo. Moreover, PPIP5K2 is capable of regulating NSCLC cells metastasis in an EMT-dependent manner. In terms of mechanism exploration, we found that PPIP5K2 knockdown can significantly inhibit the phosphorylation of AKT/mTOR signaling pathway, whereas the overexpression of PPIP5K2 resulted in converse effects. By employing AKT signaling related agonists or antagonists, we further demonstrated that PPIP5K2 regulates NSCLC tumorigenesis partly via the AKT/mTOR pathway. In conclusion, PPIP5K2 plays a key oncogenic role in NSCLC by the activation of the AKT/mTOR signaling axis. It is anticipated that targeting PPIP5K2 might emerge as a viable therapeutic approach for NSCLC patients.Keywords
Funding Information
- National Natural Science Foundation of China (82203331, 82300137, 92259102, CSTB2023NS CQ-MSX0065, JJZD2022–02, YXJL-2022-0435-0098, Y-HR2020ZD-0361)
- Natural Science Foundation of Chongqing Municipality (82203331, 82300137, 92259102, CSTB2023NS CQ-MSX0065, JJZD2022–02, YXJL-2022-0435-0098, Y-HR2020ZD-0361)
- Haiyan fund of Harbin Medical University Cancer Hospital (82203331, 82300137, 92259102, CSTB2023NS CQ-MSX0065, JJZD2022–02, YXJL-2022-0435-0098, Y-HR2020ZD-0361)
- Beijing Medical Award Foundation (82203331, 82300137, 92259102, CSTB2023NS CQ-MSX0065, JJZD2022–02, YXJL-2022-0435-0098, Y-HR2020ZD-0361)
- CSCO-Hengrui Tumor Research Fund (82203331, 82300137, 92259102, CSTB2023NS CQ-MSX0065, JJZD2022–02, YXJL-2022-0435-0098, Y-HR2020ZD-0361)
This publication has 41 references indexed in Scilit:
- Inositol pyrophosphates: Why so many phosphates?Advances in Biological Regulation, 2015
- The Vip1 Inositol Polyphosphate Kinase Family Regulates Polarized Growth and Modulates the Microtubule Cytoskeleton in FungiPLOS Genetics, 2014
- Synthetic Inositol Phosphate Analogs Reveal that PPIP5K2 Has a Surface-Mounted Substrate Capture Site that Is a Target for Drug DiscoveryChemistry & Biology, 2014
- Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon ResponsePLOS Pathogens, 2014
- Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2012
- Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowdingNature Chemical Biology, 2011
- Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight GainCell, 2010
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancerJournal of Clinical Investigation, 2010
- The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomasNature Medicine, 2007
- Inositol Pyrophosphates Mediate Chemotaxis in Dictyostelium via Pleckstrin Homology Domain-PtdIns(3,4,5)P3 InteractionsCell, 2003